{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:25:07Z","timestamp":1786951507479,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10735-026-10893-1","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:23:47Z","timestamp":1784013827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["lncRNA MEG3 and Beclin-1 as diagnostic biomarkers in serous ovarian carcinoma: molecular and immunohistochemical insights"],"prefix":"10.1007","volume":"57","author":[{"given":"Ansam M. Z.","family":"El Desoky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Mahmoud","family":"Abdelgeleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Ahmed Mohamed","family":"Abdalrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai M.","family":"Eldaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"10893_CR1","first-page":"93","volume":"22","author":"AT Ali","year":"2023","unstructured":"Ali AT, Al-Ani O, Al-Ani F (2023) Epidemiology and risk factors for ovarian cancer. Prz Menopauzalny 22:93\u2013104","journal-title":"Prz Menopauzalny"},{"key":"10893_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s10735-024-10254-w","volume":"55","author":"K Yao","year":"2024","unstructured":"Yao K, Zheng H, Tong L (2024) Expression of cancer susceptibility candidate 11 in ovarian cancer tissues and its role in doxorubicin resistance. J Mol Histol 55:1121\u20131129","journal-title":"J Mol Histol"},{"key":"10893_CR3","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.31557\/APJCP.2023.24.10.3613","volume":"24","author":"NH Amin","year":"2023","unstructured":"Amin NH, Ahmed BA, Abou-Bakr AA, Eissa SS, Nassar HR, Gad M, Eissa M (2023) The Impact of BRCA1 Expression on Survival Status in Ovarian Serous Carcinoma of Egyptian Patients. Asian Pac J Cancer Prev 24:3613\u20133620","journal-title":"Asian Pac J Cancer Prev"},{"key":"10893_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hsr2.936","volume":"5","author":"A Mazidimoradi","year":"2022","unstructured":"Mazidimoradi A, Momenimovahed Z, Allahqoli L, Tiznobaik A, Hajinasab N, Salehiniya H, Alkatout I (2022) The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer. Health Sci Rep 5:987\u2013999","journal-title":"Health Sci Rep"},{"key":"10893_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","volume":"86","author":"E Schoutrop","year":"2022","unstructured":"Schoutrop E, Moyano-Galceran L, Lheureux S, Mattsson J, Lehti K, Dahlstrand H, Magalhaes I (2022) Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Semin Cancer Biol 86:207\u2013223","journal-title":"Semin Cancer Biol"},{"key":"10893_CR6","volume-title":"Advanced Health Assessment & Clinical Diagnosis in Primary Care-E-Book: Advanced Health Assessment & Clinical Diagnosis in Primary Care","author":"JE Dains","year":"2022","unstructured":"Dains JE, Baumann LC, Scheibel P (2022) Advanced Health Assessment & Clinical Diagnosis in Primary Care-E-Book: Advanced Health Assessment & Clinical Diagnosis in Primary Care-. Elsevier Health Sciences, E-Book"},{"key":"10893_CR7","first-page":"305","volume":"14","author":"UM Zamwar","year":"2022","unstructured":"Zamwar UM, Anjankar AP (2022) Aetiology, Epidemiology, Histopathology, Classification, Detailed Evaluation, and Treatment of Ovarian Cancer. Cureus 14:305\u2013312","journal-title":"Cureus"},{"key":"10893_CR8","doi-asserted-by":"crossref","unstructured":"Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong MCS, On Behalf Of Ncd Global Health Research Group Of Association Of Pacific Rim Universities A (2022) Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study. Cancers (Basel) 14","DOI":"10.3390\/cancers14092230"},{"key":"10893_CR9","doi-asserted-by":"publisher","first-page":"113682","DOI":"10.1016\/j.jconrel.2025.113682","volume":"382","author":"J Li","year":"2025","unstructured":"Li J, Al Faruque H, Li S, Sima M, Sborov D, Hu-Lieskovan S, Werner T, Kope\u010dek J, Yang J (2025) PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer. J Controlled Release 382:113682","journal-title":"J Controlled Release"},{"key":"10893_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ (2021) LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond) 41:109\u2013120","journal-title":"Cancer Commun (Lond)"},{"key":"10893_CR11","doi-asserted-by":"publisher","first-page":"1045501","DOI":"10.3389\/fphar.2022.1045501","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, Gao J, Sun D, Jiao Q, Ma J, Cui W, Lou Y, Xu F, Li S, Li H (2022) LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases. Front Pharmacol 13:1045501","journal-title":"Front Pharmacol"},{"key":"10893_CR12","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.3390\/cancers14246032","volume":"14","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhao F, Li W, Song G, Kasim V, Wu S (2022) The biological roles and molecular mechanisms of long non-coding RNA MEG3 in the hallmarks of cancer. Cancers 14:6032\u20136040","journal-title":"Cancers"},{"key":"10893_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM (2023) Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol 24:560\u2013575","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10893_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/JVI.72.11.8586-8596.1998","volume":"72","author":"XH Liang","year":"1998","unstructured":"Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, Herman B, Levine B (1998) Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72:858\u2013870","journal-title":"J Virol"},{"key":"10893_CR15","doi-asserted-by":"crossref","unstructured":"Hussein S, Waley AB, Abdelgeleel HM, Saadawy SF, Ibrahim SM, Hemeda M, Sameh R (2025) LC3 and beclin-1 immunohistochemical and gene expressions in bladder cancer. Clin Transl Oncol","DOI":"10.1007\/s12094-025-04002-z"},{"key":"10893_CR16","doi-asserted-by":"crossref","unstructured":"Tran S, Fairlie WD, Lee EF (2021) BECLIN1: Protein Structure, Function and Regulation. Cells;10:112-9","DOI":"10.3390\/cells10061522"},{"key":"10893_CR17","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3892\/ol.2015.2950","volume":"9","author":"H Ying","year":"2015","unstructured":"Ying H, Qu D, Liu C, Ying T, Lv J, Jin S, Xu H (2015) Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers. Oncol Lett 9:1759\u20131763","journal-title":"Oncol Lett"},{"key":"10893_CR18","doi-asserted-by":"crossref","unstructured":"Kicman A, Niczyporuk M, Kulesza M, Motyka J, \u0141awicki S (2022) Utility of matrix metalloproteinases in the diagnosis, monitoring and prognosis of ovarian cancer patients. Cancer Manage Res 3359\u20133382","DOI":"10.2147\/CMAR.S385658"},{"key":"10893_CR19","doi-asserted-by":"publisher","first-page":"175883592412332","DOI":"10.1177\/17588359241233225","volume":"16","author":"A Ghose","year":"2024","unstructured":"Ghose A, McCann L, Makker S, Mukherjee U, Gullapalli SVN, Erekkath J, Shih S, Mahajan I, Sanchez E, Uccello M, Moschetta M, Adeleke S, Boussios S (2024) Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4. Ther Adv Med Oncol 16:17588359241233225","journal-title":"Ther Adv Med Oncol"},{"key":"10893_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ncrna.2022.02.004","volume":"7","author":"O Beylerli","year":"2022","unstructured":"Beylerli O, Gareev I, Sufianov A, Ilyasova T, Guang Y (2022) Long noncoding RNAs as promising biomarkers in cancer. Noncoding RNA Res 7:66\u201370","journal-title":"Noncoding RNA Res"},{"key":"10893_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3389\/fcell.2022.997633","volume":"10","author":"J Xu","year":"2022","unstructured":"Xu J, Wang X, Zhu C, Wang K (2022) A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. Front Cell Dev Biol 10:990\u2013997","journal-title":"Front Cell Dev Biol"},{"key":"10893_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.18632\/oncotarget.15955","volume":"8","author":"YL Xiu","year":"2017","unstructured":"Xiu YL, Sun KX, Chen X, Chen S, Zhao Y, Guo QG, Zong ZH (2017) Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3. Oncotarget 8:456\u2013466","journal-title":"Oncotarget"},{"key":"10893_CR23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00011-018-1186-z","volume":"67","author":"J Wang","year":"2018","unstructured":"Wang J, Xu W, He Y, Xia Q, Liu S (2018) )LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN. Inflamm Res 67:927\u2013936","journal-title":"Inflamm Res"},{"key":"10893_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12935-020-01259-y","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xu Y, Ding L, Yu L, Zhang B, Wei D (2020) LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression. Cancer Cell Int 20:181\u2013189","journal-title":"Cancer Cell Int"},{"key":"10893_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12967-024-04929-x","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Lou S, Zhang J, Zhao S, Lou G (2024) m(6)A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway. J Transl Med 22:113","journal-title":"J Transl Med"},{"key":"10893_CR26","doi-asserted-by":"crossref","unstructured":"Chiok K, Bose S (2022) A novel viral regulatory network for autophagy induction: respiratory Syncytial Virus NS2 protein regulates autophagy by modulating BECN1 ISGylation and protein stability, vol 1. Autophagy reports, pp 219\u2013222","DOI":"10.1080\/27694127.2022.2076769"},{"key":"10893_CR27","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.2147\/OTT.S266389","volume":"13","author":"YJ Fang","year":"2020","unstructured":"Fang YJ, Jiang P, Zhai H, Dong JS (2020) )LncRNA GAS8-AS1 inhibits ovarian cancer progression through activating beclin1-mediated autophagy. Onco Targets Ther 13:10431\u201310440","journal-title":"Onco Targets Ther"},{"key":"10893_CR28","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41419-022-05286-7","volume":"13","author":"W Song","year":"2022","unstructured":"Song W, Zeng Z, Zhang Y, Li H, Cheng H, Wang J, Wu F (2022) )CircRNF144B\/miR-342-3p\/FBXL11 axis reduced autophagy and promoted the progression of ovarian cancer by increasing the ubiquitination of Beclin-1. Cell Death Dis 13:857\u2013889","journal-title":"Cell Death Dis"},{"key":"10893_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/1541-7786.MCR-16-0132","volume":"15","author":"L DeVorkin","year":"2017","unstructured":"DeVorkin L, Hattersley M, Kim P, Ries J, Spowart J, Anglesio MS, Levi SM, Huntsman DG, Amaravadi RK, Winkler JD, Tinker AV, Lum JJ (2017) Autophagy inhibition enhances sunitinib efficacy in clear cell ovarian carcinoma. Mol Cancer Res 15:250\u2013258","journal-title":"Mol Cancer Res"},{"key":"10893_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.31083\/ph.2018.8514","volume":"73","author":"F Long","year":"2018","unstructured":"Long F, Liu W, Jia P, Wang H, Jiang G, Wang T (2018) )HIF-1\u03b1-induced autophagy contributes to cisplatin resistance in ovarian cancer cells. Pharmazie 73:533\u2013536","journal-title":"Pharmazie"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10893-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10893-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10893-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:48:59Z","timestamp":1786949339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10893-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10893"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10893-1","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"234"}}